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Abstract Guanylate cyclase-activating protein 1 (GCAP-1) is a
Ca2+-sensing protein in vertebrate photoreceptor cells. It
activates a membrane-bound guanylate cyclase. Three of four
cysteines present in wild-type GCAP-1 were accessible to the
thiol-modifying reagent 5,5P-dithio-bis-(2-nitrobenzoic acid) in
the presence of Ca2+. Only Cys106 became exposed to the
solvent after Ca2+-chelation. Since Cys106 is located in EF-hand
3, we could determine an apparent KD of 2.9 WM for Ca2+
binding to this site with a fast off-rate (tV2 ms). We conclude
that the rapid dissociation of Ca2+ from EF-hand 3 in GCAP-1
triggers activation of guanylate cyclase in rod cells. ß 2001
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.




Neuronal calcium sensor (NCS) proteins constitute a family
of EF-hand Ca2-binding proteins [1,2]. Known members of
this family among others are recoverin and guanylate cyclase-
activating proteins (GCAPs) which play key roles as Ca2
sensors in vertebrate phototransduction and are speci¢cally
expressed in rod and cone cells [3]. Three di¡erent GCAPs
are known so far to activate the photoreceptor membrane
guanylate cyclase (ROS-GC1) in isolated rod outer segments
(ROS) at 100^300 nM of free [Ca2]. Activation of ROS-GC1
by GCAPs is a key step in restoration of the cGMP level in
rod and cone cells after rapid hydrolysis of cGMP by illumi-
nation. Regulation of ROS-GC1 by changing Ca2-levels is
one of the main mechanisms of light adaptation in photore-
ceptor cells [4].
GCAPs have four EF-hand motifs, but only three EF-
hands are functional Ca2-binding sites. As most NCS protein
GCAPs contain a consensus site for N-terminal myristoyla-
tion. The functional signi¢cance of myristoylation in GCAPs
is not known and may di¡er among the di¡erent isoforms.
For example, non-myristoylated GCAP-1 shows a di¡erent
activation pro¢le of ROS-GC1 than myristoylated GCAP-1,
but no such di¡erence was observed for GCAP-2 [4^6]. An-
other characteristic feature of GCAPs is their property to bind
to ROS-GC1 at low and at high [Ca2]. Therefore the current
concept of cyclase regulation by GCAPs favors a Ca2-in-
duced switch of GCAP from a basal or inhibitory state to
an activator state while it is bound to cyclase [7^9]. A prom-
inent feature of the primary structure of GCAP-1 are four
cysteine residues in distant parts of the protein. In order to
gain more information about the functional and/or structural
role of these cysteines we investigated cysteine mutants of
GCAP-1. In particular, we explored the use of internal cys-
teines as internal monitors for Ca2-induced structural
changes.
2. Materials and methods
2.1. Construction and expression of GCAP 1 cysteine mutants
The four cysteine residues in GCAP1 have been exchanged against
alanines in di¡erent number and combination. Standard cloning
methods [10] and oligonucleotide-directed mutagenesis were per-
formed using cDNA of GCAP-1 [5] as a template to generate mutated
GCAP-1. In a two-step PCR inner mutagenesis primers (for C18A
and C29A: 5PGGGCGCCTCTGTCATGAACTTCTTGTACCAC-
TGGTGGGCCTCGGTGCTGCTCAG-3P ; for C106A: 5P-CGT-
GGACGGCAACGGAGCGATCGACCGCGACGAGCTGC-3P ; for
C125A: 5P-GGCGGTCATGGTCGAGTCGCTCGCGGGGTTAAT-
GGCTCGGATGGC-3P) were used in combination with outer prim-
ers. An NdeI restriction site was introduced upstream of the start
codon and a BamHI site downstream of the stop codon. The resulting
mutated GCAP1 genes were veri¢ed by sequencing and introduced in
corresponding sites of pET11a (Novagen). To express the proteins,
competent Escherichia coli BL21-CodonPlus(DE3) cells (Stratagene)
were transformed. Single colonies were cultivated in dYT to an
OD600 of 0.6 and induced with 1 mM IPTG for 4 h. Cells were
harvested and resuspended in 50 mM Tris pH 8.0.
2.2. Puri¢cation of GCAP-1 and its mutants
All puri¢cation steps were performed at 4‡C. Resuspended cells
were disrupted by passaging through a French press (SLM Aminco).
The cell lysate was then separated from cell debris by centrifugation.
Subsequent puri¢cation from the supernatant was achieved as de-
scribed [8]. Puri¢ed wild-type (wt) and mutant GCAP-1 (0.5^3 ml
protein solution of 1^3 mg/ml) were dialyzed against 50 mM ammo-
nium bicarbonate bu¡er. Aliquots of 1 mg were lyophilized by a
Speedvac concentrator and then stored at 380‡C until further use.
2.3. Preparation of ROS membranes and guanylate cyclase assay
ROS were prepared from freshly collected bovine eyes as before
[11]. The predominant guanylate cyclase in ROS preparations is
ROS-GC1 (K.-W. Koch, unpublished observation). For reconstitu-
tion experiments, ROS membranes were prepared as described [5].
Varying concentration of GCAP-1 or its mutants were added to 10
Wl of washed ROS membranes to give a total volume of 20 Wl. The
0014-5793 / 01 / $20.00 ß 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 1 ) 0 3 0 9 4 - 0
*Corresponding author. Fax: (49)-2461-614216.
E-mail address: k.w.koch@fz-juelich.de (K.-W. Koch).
Abbreviations: ROS, rod outer segments; ROS-GC1, photoreceptor
membrane guanylate cyclase; GCAP, guanylate cyclase-activating
protein; DTNB, 5,5P-dithio-bis-(2-nitrobenzoic acid); TNB, 5-thio-2-
nitrobenzoic acid; wt, wild-type; Rh, rhodopsin
FEBS 25483 20-11-01
FEBS 25483 FEBS Letters 508 (2001) 355^359
free [Ca2] was adjusted by Ca2/EGTA bu¡er calculated with a Ca2
bu¡er program CHELATOR [12]. Incubation was performed at room
temperature under very dim red light. The activity of ROS-GC1 was
determined by a HPLC chromatography assay as described before [5].
2.4. Counting disul¢de bonds by iodoacetate derivatives
Integral numbers of disul¢de bonds in GCAP-1 were counted as in
[13,14]. This approach examines the charge di¡erences that are intro-
duced by speci¢c chemical modi¢cations of the cysteines using the
alkylation reagents iodoacetamide (IAM) and iodoacetic acid (IAA).
2.5. Thiol reactivity of GCAP-1 and its cysteine mutants
Quantitative determination of thiol groups in solution was per-
formed by recording the formation of 5-thio-2-nitrobenzoic acid
(TNB) from 5,5P-dithio-bis-(2-nitrobenzoic acid) (DTNB) at 412 nm
[15]. A fresh solution of DTNB (12.5 mM) was prepared by dissolving
it in 0.1 M Tris, pH 8.0 and sonicating for 5 min at 80^100 W. Thiol
reactivity of GCAP-1 wt and mutants was measured by the addition
of 50^250 WM DTNB into a cuvette containing 6^12 WM of GCAP-1,
50 mM HEPES pH, 7.4, 100 mM NaCl and either 100 WM CaCl2 or
2 mM EGTA. The time course of TNB formation at 412 nm was
recorded after injection of DTNB using a Shimadzu UV-2101PC UV/
VIS scanning spectrophotometer or using an SLM-Aminco DW-2000
UV/VIS spectrophotometer in dual wavelength mode with monochro-
mators set at 412 nm and 750 nm. When samples were preincubated
with CaCl2, EGTA was injected 5 min after application of DTNB. In
a second set of experiments the order of CaCl2 and EGTA application
was reversed (CaCl2 in excess). Thiol reactivity of GCAP-1 and its
cysteine mutants was also measured as a function of the free [Ca2].
All experiments were performed with non-myristoylated wt and mu-
tants of GCAP-1. Presence of the myristoyl group changed the acces-
sibility of cysteines in a complex matter (J.-Y. Hwang and K.-W.
Koch, in preparation)
3. Results
3.1. GCAP-1 does not contain intramolecular disul¢de bonds
GCAP-1 contains four cysteines and could theoretically
harbor one or two disul¢de bridges. We tested the presence
of hypothetical disul¢de bonds by treatment of GCAP-1 with
IAM and iodoacetate at di¡erent concentrations of DTT ac-
cording to [13,14]. Di¡erent electrophoretic mobilities of
GCAP-1 would indicate the presence of intramolecular disul-
¢de bonds, which we did not observe. Consistent with this
initial observation was that all four cysteines rapidly reacted
with DTNB (see below).
3.2. Monitoring the exposition of thiol groups of GCAP-1
The cysteine residues in GCAP-1 were titrated by DTNB in
either the presence or absence of Ca2. The reaction of DTNB
with GCAP-1 caused a time-dependent labeling by TNB. The
rate of covalent modi¢cation of free sulfhydryl groups with
DTNB solution was dependent on the relative accessibility
and the chemical environment of the cysteines. From a cys-
teine standard curve the number of reactive cysteines in a
protein can be calculated. The reaction of 5 WM GCAP-1
with DTNB as a function of time is shown in Fig. 1.
The absorbance at 412 nm (A412) of 5 WM GCAP-1 in the
presence of CaCl2 was 0.205, which corresponds to three cys-
teines in GCAP-1. After 300 s, injection of EGTA caused an
additional increase in A412 of 0.074, which corresponded to
5.4 WM of free thiol or one cysteine (Fig. 1A). When the
injection of CaCl2 and EGTA was reversed, the change in
A412 was 0.290 with EGTA and after 300 s, injection of CaCl2
caused no change (Fig. 1B). These data demonstrated that in
the presence of CaCl2, three cysteines were exposed to the
solvent and one cysteine remains buried in wt GCAP-1. Che-
lating Ca2 with 2 mM EGTA led to the exposure of the
buried cysteine. In contrast, when GCAP-1 was preincubated
with EGTA, all four cysteines were exposed and were acces-
sible to DTNB. These results indicated that cysteines in
GCAP-1 are sensitive to Ca2-induced conformational
changes in their environment. Therefore, we constructed cys-
teine mutants of GCAP-1 to further investigate the use of
cysteine residues as internal monitors. The ¢rst cysteine
Cys18 is located in the K-helix of the non-functional EF-1,
Cys29 in the loop of EF-1, Cys106 in the loop of EF-3, and
Cys125 between EF-3 and EF-4. The single mutants were
termed as C18A, C29A, C106A, and C125A. The triple mu-
tants, where three cysteines were replaced by alanines, were
termed CAAA (C29W106W125A), ACAA (C18W106W125A),
AACA (C18W29W125A), and AAAC (C18W29W106A). In the
quadruple mutant, termed AAAA, all four cysteines were sub-
stituted by alanines.
3.3. Activation of ROS-GC1 by cysteine mutants of GCAP-1
We tested, whether the mutations impaired the function of
GCAP-1 as an activator of ROS-GC1. Activation of ROS-
GC1 in washed ROS membranes was measured as a function
of increasing concentrations of mutant GCAPs or as a func-
tion of free [Ca2] (see Fig. 2 for the quadruple mutant
AAAA as example). Results for all mutant proteins are listed
in Table 1. In comparison to the wt, single cysteine mutants
C18A, C29A and C106A activated cyclase to a lower degree,
but C125A reached a 50% higher maximal activation. The
EC50 values were for all single cysteine mutants lower, which
indicated that the apparent a⁄nity of the mutants for ROS-
GC1 was higher. Maximal activation of cyclase by the triple
Fig. 1. Cysteine fraction of wt GCAP-1 with DTNB. A: Time course of thiol reactivity was measured at 412 nm (formation of TNB). wt
GCAP-1 (5 WM) was preincubated with 100 WM CACl2 and reaction was started by injection of 50 WM DTNB. After 300 s 2 mM EGTA was
injected and the response was recorded for 300 s. B: Order of CaCl2 and EGTA application was reversed.
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mutants was less variable, apparent a⁄nity was also higher in
comparison to wt. Activity at high Ca2 was in most cases
(C29A, C106A, all triple mutants and the quadruple mutant)
lower, which indicated an inhibitory e¡ect that was stronger
than observed with the wt.
When we tested the activation pro¢le of guanylate cyclase
by GCAP-1 mutants over a range of free [Ca2] from 1 nM to
1 mM, single cysteine mutants di¡ered also from triple cys-
teine mutants mainly by two aspects (Table 1): free [Ca2] at
which activation is halfmaximal (IC50) was always lower in
the case of triple mutants as in the case of single mutants.
Activation was cooperative with an Hill coe⁄cient of n = 1.5^
1.7 in triple mutants but no cooperativity was observed with
single mutants. Thus single cysteine mutants displayed similar
properties as the non-myristoylated wt (Table 1), but triple
mutants were more like native myristoylated GCAP-1 in
whole ROS [5]. In line with this observation were the results
obtained with the quadruple mutant (Table 1 and Fig. 2),
which showed almost identical properties as native myristoy-
lated GCAP-1 in whole ROS. Additionally, the quadruple
mutant showed a very pronounced inhibitory e¡ect at high
[Ca2] (Fig. 2). Thus, mutations did not impair the general
function of GCAP-1, instead some aspects of its Ca2-sensi-
tive regulation were modi¢ed.
3.4. Thiol reactivity of single cysteine mutants
The reactivity of the single cysteine mutants with DTNB is
shown in Fig. 3. Three mutants, C18A, C29A and C125A
showed an immediate reaction of two cysteines with DTNB
in the presence of Ca2 and the exposure of an additional
cysteine after injection of EGTA. All three cysteines in mutant
C106A reacted immediately with DTNB in the presence of
Ca2. No exposure of an additional cysteine was observed
after injection of EGTA. This result clearly demonstrated
that the cysteine at position 106 is buried in the presence of
Ca2.
3.5. Reactivity of triple cysteine mutants
To monitor the reactivity of each cysteine residue sepa-
rately, triple cysteine mutants were investigated. Fig. 3 illus-
trates the reactivity of single cysteines in all four mutants
towards DTNB. A very rapid development of the signal was
recorded with the mutants CAAA and AAAC in the presence
of Ca2. Injection of EGTA did not elicit a further response.
A signi¢cantly slower signal in the presence of Ca2 was seen
with mutant ACAA, but also no signal after injection of
EGTA. Only mutant AACA reacted with DTNB after injec-
tion of EGTA and in the presence of Ca2 increase of absor-
bance was very slow. These observations agree with results
that the cysteine residue at position 106 is buried in GCAP-
1 in high [Ca2] and that it becomes exposed in the absence of
Ca2.
3.6. Thiol reactivity of ACAA and AACA as a function of
[Ca2+]free
Recordings in the presence of Ca2 showed di¡erent ki-
netics (Fig. 3). A slower increase in A412 was observed when
Cys29 was present, but absent when it was substituted by Ala.
Fig. 2. Activation of ROS-GC1 by the GCAP-1 mutant AAAA. A: ROS membranes containing ROS-GC1 were incubated at increasing con-
centrations of mutant AAAA at 2 mM CaCl2 or 2 mM EGTA (see inset) to measure guanylate cyclase activity. Halfmaximal activation (EC50)
was at 0.682 WM. B: Guanylate cyclase activity was measured as a function of free [Ca2]. ROS membranes were incubated with 10 WM mu-
tant AAAA at varying [Ca2]. Activity was halfmaximal at 0.293 WM free [Ca2]. Hill coe⁄cient was n = 1.7. Open circles are control determi-
nations without added GCAP-1 mutant. Data points are from triplicates.
Table 1
Properties of GCAP-1 mutants




EC50 [Protein] (WM) x-fold activation IC50 [Ca2]free
(WM)
n (Hill coe⁄cient)
GCAP-1 12.39 2.14 0.85 5.8 2.817 0.3
C18A 10.13 2.86 0.53 3.5 10.368 0.6
C29A 8.28 1.77 0.41 4.7 5.190 0.7
C106A 6.01 1.34 0.36 4.4 2.083 1.2
C125A 17.97 2.80 0.35 6.4 4.254 1.0
CAAA 9.98 1.51 0.78 6.6 0.499 1.7
ACAA 9.47 1.71 0.82 5.5 0.721 1.5
AACA 11.84 1.12 0.49 10.6 0.551 1.5
AAAC 12.85 1.72 0.49 7.5 1.052 1.5
AAAA 12.23 1.22 0.68 10.0 0.293 1.7
Activity is expressed as nmol cGMP/min/mg rhodopsin (Rh).
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Results with the triple cysteine mutants (ACAA and AACA)
also indicated di¡erent kinetics of DTNB reactivity as a func-
tion of [Ca2]. Thus we compared the reactivities of cysteines
at position 29 and 106 by measuring the time-dependent
change in absorbance as a function of [Ca2] (Fig. 4). The
reactivity (and therefore accessibility) of the cysteine in
ACAA displayed di¡erent kinetics at di¡erent [Ca2] (Fig.
4A). We determined di¡erent time constants by ¢tting the
Fig. 3. Cysteine reaction of single cysteine mutants of GCAP-1 with DTNB. Time course of thiol reactivity was recorded at 412 nm according
to the same protocol as in Fig. 1A (arrows indicate injection of EGTA). Upper traces show recordings with single mutants, lower traces with
triple mutants. Recordings were obtained with 10 WM C18A and 6 WM CAAA (A), 12 WM C29A and 6 WM ACAA (B), 5 WM C106A and 10
WM AACA (C) and 8 WM C125A and 10 WM AAAC (D).
Fig. 4. Cysteine reaction of mutants ACAA (A) and AACA (B) with DTNB as a function of time and calcium concentration. Thiol reactivity
was measured for various concentrations of Ca2/EGTA bu¡er. The reaction was started by the addition of DTNB directly to the cuvette to a
¢nal concentration of 100^250 WM and monitored using an SLM-Aminco DW-2000 UV/VIS spectrophotometer in dual wavelength mode with
monochromators set at 412 nm and 750 nm. Recordings were ¢tted to a modi¢ed exponential growth for non-linear curve ¢tting;
y = y03A1Ue3x=t1. The calculated time constants (t1) obtained from recordings with ACAA (C) and AACA (D) were plotted against [Ca2]free.
The solid line represents the best ¢t to the Hill equation.
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data to a single exponential. Plotting the time constants as a
function of [Ca2] yielded an apparent KD of approximately
100 WM (Fig. 4C).
A di¡erent titration was obtained with the triple mutant
AACA (Fig. 4B). Almost no reactivity was observed at high
[Ca2]free. At intermediate [Ca2]free (3 WM), the reaction to-
wards DTNB occurred at a slow rate when compared with
ACAA. Finally, at low [Ca2] the reaction proceeded with
similar fast kinetics as in the case of ACAA. A plot of time
constants as a function of [Ca2] was ¢tted to a Hill equation
yielding an apparent KD = 2.9 WM and a Hill coe⁄cient
n = 1.4.
4. Discussion
The Ca2-dependent activation pro¢le of cysteine mutants
exhibited some interesting di¡erences in comparison to wt
GCAP-1 (Table 1). Cysteines in position 18, 29 and 125
seem to participate in the Ca2-sensitive regulation of cyclase,
because exchange of C to A increased the IC50 at which acti-
vation of cyclase is halfmaximal. Surprising was the result that
the triple mutants and the mutant AAAA resembled more the
myristoylated wt GCAP-1. For example, the IC50 and the
degree of cooperativity we determined with mutant AAAA
were like myristoylated wt GCAP-1. We conclude from these
observations that the substitution of cysteines by more hydro-
phobic alanines in at least four positions can compensate the
lack of the myristoyl group. GCAP-1 needs a hydrophobic
environment close to Cys18, Cys29, Cys106, Cys125 to acti-
vate cyclase at physiologically relevant free [Ca2].
All cysteines in GCAP-1 reacted with the thiol-modifying
reagent DTNB, but accessibility to C29 and C106 was depen-
dent on the free [Ca2]. These two cysteines are located in EF-
hand 1 and 3, respectively. The Ca2-dependent titration of
thiol reactivities of mutants ACAA and AACA in Fig. 4
clearly exhibited di¡erent Ca2-sensitivities. We interpret
these di¡erent Ca2-sensitivities as di¡erent apparent a⁄nities
of EF-hand 1 and 3 for Ca2. The low a⁄nity of EF-hand 1
(KDV100 WM) is consistent with the view that EF-hand 1
does not bind Ca2 in the physiologically relevant range.
The apparent a⁄nity of EF-hand 3 for Ca2 was of inter-
mediate a⁄nity (KD = 2.9 WM). However, halfmaximal activa-
tion of cyclase by the AACA mutant occurred at much lower
free [Ca2] (IC50 = 0.551 WM in Table 1) and is cooperative.
Thus, EF-hand 2 and/or EF-hand 4 must have a much higher
a⁄nity for Ca2.
We assume that the on-rate of Ca2 to all three EF-hands is
under control of di¡usion (k1 = 2U108 M31 s31 [16] ;
KD = kÿ1/k1). An apparent KD of 2.9 WM of Ca2 for EF-
hand 3 in GCAP-1 would then result in an o¡-rate of
k31 = 5.8U1033 s31 with a corresponding time constant of
V2 ms.
This dissociation rate of Ca2 from the EF-hand 3 in
GCAP-1 is fast enough to trigger a conformational change
in GCAP-1 within the time frame of the photoresponse (less
than 200 ms). Therefore, GCAP-1 would ¢t perfectly into the
group of Ca2-trigger proteins with rapid o¡ kinetics (mean
residence time of Ca2 are a few ms) [17]. Relative a⁄nities of
Ca2 among di¡erent groups of Ca2-binding proteins depend
critically on the ninth position in an EF-hand [18]. If EF-
hands contain a Glu at the ninth position, they release Ca2
with slower dissociation rates than EF-hands that contain
either an amino acid with a shorter side chain (Asp) or an
uncharged side chain (Gln). Ca2-bu¡er proteins like parval-
bumin have slower dissociation rates of Ca2 than Ca2-trig-
ger like calmodulin or troponin C (for review see [17]). EF-
hand 3 in GCAP-1 contains an Asp at the ninth position,
which is typical for a Ca2-trigger.
We conclude that dissociation of Ca2 from EF-hand 3 in
GCAP-1 is the ¢rst critical step in activating ROS-GC1. Re-
lease from this site then triggers a conformational change in
the vicinity of EF-hand 3. Our hypothesis is consistent with a
previous tryptophan £uorescence study [16] that reported
on a Ca2-induced major conformational change around
EF-hand 3.
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